Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Trinity Biotech (TRIB) Equity Ratio (2016 - 2025)

Trinity Biotech's Equity Ratio history spans 10 years, with the latest figure at 0.68 for Q4 2025.

  • On a quarterly basis, Equity Ratio fell 100.96% to 0.68 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.68, a 100.96% decrease, with the full-year FY2025 number at 0.68, down 100.96% from a year prior.
  • Equity Ratio hit 0.68 in Q4 2025 for Trinity Biotech, down from 0.34 in the prior quarter.
  • Over the last five years, Equity Ratio for TRIB hit a ceiling of 0.15 in Q2 2022 and a floor of 0.68 in Q4 2025.
  • Historically, Equity Ratio has averaged 0.12 across 5 years, with a median of 0.0 in 2021.
  • The widest YoY moves for Equity Ratio: up 3812.72% in 2022, down 6242.64% in 2022.
  • Tracing TRIB's Equity Ratio over 5 years: stood at 0.0 in 2021, then plummeted by 780.55% to 0.02 in 2022, then plummeted by 1605.55% to 0.4 in 2023, then increased by 15.47% to 0.34 in 2024, then plummeted by 100.96% to 0.68 in 2025.
  • Business Quant data shows Equity Ratio for TRIB at 0.68 in Q4 2025, 0.34 in Q4 2024, and 0.4 in Q4 2023.